Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Estrogens × 1 year × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Estrogen Receptor Positive Breast Cancer 1

Interventions

pembrolizumab 462 Carboplatin 330 Specimen Handling 325 Cisplatin 288 Magnetic Resonance Spectroscopy 287 Nivolumab 274 Cyclophosphamide 260 Paclitaxel 231 Radiotherapy 217 Biopsy 200 Gemcitabine 192 Bevacizumab 183 Dexamethasone 152 durvalumab 146 Rituximab 144 Capecitabine 139 atezolizumab 138 Oxaliplatin 138 Docetaxel 135 Fluorouracil 134 venetoclax 131 Ipilimumab 121 Etoposide 120 Drug Therapy 120 Doxorubicin 113 Prednisone 111 Lenalidomide 109 Radiosurgery 104 Pemetrexed 98 Leucovorin 98

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02238808 2025-06-26

PRESTO

AHS Cancer Control Alberta

Phase 2 Active not recruiting

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡